Zhang TD, Cao S, Ren HY, Li YM, Yuan YM. Cemented vertebra and adjacent vertebra refractured in a chronic kidney disease-mineral and bone disorder patient: A case report. World J Clin Cases 2024; 12(10): 1804-1809 [PMID: 38660087 DOI: 10.12998/wjcc.v12.i10.1804]
Corresponding Author of This Article
Yi-Ming Yuan, MM, Doctor, Department of Orthopedics, Civil Aviation General Hospital, No. 1 Gaojing Street, Chaoyang District, Beijing 100123, China. yim122@126.com
Research Domain of This Article
Orthopedics
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Ti-Dong Zhang, Shuai Cao, Hui-Yong Ren, Yu-Min Li, Yi-Ming Yuan, Department of Orthopedics, Civil Aviation General Hospital, Beijing 100123, China
Author contributions: Yuan YM and Li YM contributed to the conceptualization and project administration; Zhang TD, Cao S, Ren HY investigated the case and data; Zhang TD, Cao S contributed to the visualization; Zhang TD wrote the manuscript; Yuan YM, Cao S reviewed and edited the manuscript; All authors have read and approve the final manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yi-Ming Yuan, MM, Doctor, Department of Orthopedics, Civil Aviation General Hospital, No. 1 Gaojing Street, Chaoyang District, Beijing 100123, China. yim122@126.com
Received: November 14, 2023 Peer-review started: November 14, 2023 First decision: January 23, 2024 Revised: February 5, 2024 Accepted: March 8, 2024 Article in press: March 8, 2024 Published online: April 6, 2024 Processing time: 139 Days and 18.9 Hours
Abstract
BACKGROUND
Although percutaneous vertebral augmentation (PVA) is a commonly used procedure for treating vertebral compression fracture (VCF), the risk of vertebral refracture should be considered. Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a systemic disease of mineral and bone metabolism. It is associated with an increased risk of fracture. Few studies have reported the use of PVA in patients with CKD-MBD. We herein report a rare case wherein the cemented vertebra and the adjacent vertebra refractured simultaneously in a CKD-MBD patient after PVA.
CASE SUMMARY
A 74-year-old man suffered from low back pain after taking a fall about 3 wk ago. According to physical examination, imaging and laboratory findings, diagnoses of T12 VCF, CKD-MBD, and chronic kidney disease stage 5 were established. He then received percutaneous vertebroplasty at T12 vertebra. Fourteen weeks later, he presented with T12 and L1 vertebral refractures caused by lumbar sprain. Once again, he was given PVA which was optimized for the refractured vertebrae. Although the short-term postoperative effect was satisfactory, he reported chronic low back pain again at the 3-month follow-up.
CONCLUSION
It is necessary that patients with CKD-MBD who have received PVA are aware of the adverse effects of CKD-MBD. It may increase the risk of vertebral refracture. Furthermore, the PVA surgical technique needs to be optimized according to the condition of the patient. The medium- and long-term effects of PVA remain uncertain in patients with CKD-MBD.
Core Tip: This is a rare case wherein the cemented vertebra and the adjacent vertebra refractured simultaneously in a chronic kidney disease-mineral and bone disorder (CKD-MBD) patient after percutaneous vertebral augmentation (PVA). He was given PVA once more, which was optimized for the refractured vertebrae. While, the medium- and long-term effects were not satisfactory. It is necessary that patients with CKD-MBD who have received PVA are aware of the adverse effects of CKD-MBD.
